{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T22:37:42Z","timestamp":1776119862696,"version":"3.50.1"},"reference-count":35,"publisher":"FapUNIFESP (SciELO)","issue":"9B","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq. Neuro-Psiquiatr."],"published-print":{"date-parts":[[2013,9]]},"abstract":"<jats:p>The central nervous system demyelinating diseases are a group of disorders with different etiologies, characterized by inflammatory lesions that are associated with loss of myelin and eventually axonal damage. In this group the most studied ones are multiple sclerosis (MS), neuromyelitis optic (NMO) and acute disseminated encephalomyelitis (ADEM). The cerebrospinal fluid is essential to differentiate between these different syndromes and to define multiple sclerosis, helping to assess the probability of Clinical Isolated Syndrome turn into multiple sclerosis.<\/jats:p>","DOI":"10.1590\/0004-282x20130151","type":"journal-article","created":{"date-parts":[[2013,10,29]],"date-time":"2013-10-29T13:11:55Z","timestamp":1383052315000},"page":"685-688","source":"Crossref","is-referenced-by-count":9,"title":["Cerebrospinal fluid analysis in the context of CNS demyelinating diseases"],"prefix":"10.1590","volume":"71","author":[{"given":"Sandro Luiz de Andrade","family":"Matas","sequence":"first","affiliation":[{"name":"Senne Liquor Diagnostico; UNIFESP-EPM"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felipe von","family":"Glehn","sequence":"additional","affiliation":[{"name":"Senne Liquor Diagnostico; UNICAMP"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo Bruniera Peres","family":"Fernandes","sequence":"additional","affiliation":[{"name":"Senne Liquor Diagnostico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos Augusto Senne","family":"Soares","sequence":"additional","affiliation":[{"name":"Senne Liquor Diagnostico"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"key":"ref1","first-page":"547","article-title":"The immunology of inflammatory demyelinating disease. In: Confavreux C, Lassmann H, McDonald I, Miller D, Noseworthy J, Smith K, Wekerle H (Eds). McAlpine's Multiple Sclerosis","volume":"2006","author":"Wekerle H","journal-title":"London"},{"issue":"(Suppl 3)","key":"ref2","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1212\/WNL.0b013e31818f3d35","article-title":"Strategies for optimal disease management, adherence, and outcomes in multiple sclerosis patients","volume":"71","author":"Ross A","year":"2008","journal-title":"Neurology"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMe0806738","article-title":"Multiple lessons for multiple sclerosis","volume":"359","author":"Hauser S L","year":"2008","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","article-title":"Multiple sclerosis","volume":"372","author":"Compston A","year":"2008","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S1474-4422(10)70094-6","article-title":"Multiple sclerosis: risk factors, prodromes, and potential causal pathways","volume":"9","author":"Ramagopalan SV","year":"2010","journal-title":"Lancet Neurol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jneuroim.2006.06.032","article-title":"Roles of immunoglobulins and B cells in multiple sclerosis: From pathogenesis to treatment","volume":"180","author":"Antel J","year":"2006","journal-title":"J Neuroimmunol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1001\/archneur.62.6.865","article-title":"Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis","volume":"62","author":"Freedman MS","year":"2005","journal-title":"Arch Neurol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s004150200026","article-title":"Oligoclonal bands and antibody responses in multiple sclerosis","volume":"249","author":"Correale J","year":"2002","journal-title":"J Neurol"},{"key":"ref9","first-page":"2","article-title":"Oligoclonal bands in Devic's neuromyelitis optica and multiple sclerosis: differences in repeated cerebrospinal fluid examinations","volume":"10","author":"Bergamaschi R","year":"2004","journal-title":"MultScler"},{"key":"ref10","first-page":"209","article-title":"Inflammatory and demyelinating disorders. In: David N Irani (Ed). Cerebrospinal fluid in clinical practice. Philadelphia, Ed","volume":"2009","author":"Calabresi PA","journal-title":"Saunders Elsevier"},{"key":"ref11","first-page":"117","article-title":"O exame do l\u00edquido cefalorraqueano. In: Tilbery CB (Ed). Esclerose m\u00faltipla no Brasil. Aspectos cl\u00ednicos e terap\u00eauticos. S\u00e3o Paulo, Ed","volume":"2005","author":"Senne C","journal-title":"Atheneu"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0165-5728(98)00174-X","article-title":"Cerebrospinal fluid abnormalities in a phase III trial of Avonex (IFNbeta-1a) for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group","volume":"93","author":"Rudick RA","year":"1999","journal-title":"J Neuroimmunol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1212\/WNL.56.8.1084","article-title":"MRI and CSF oligoclonal bands after autologous hematopoietic stem cell transplantation in MS","volume":"56","author":"Saiz A","year":"2001","journal-title":"Neurology"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1001\/archneurol.2010.99","article-title":"Changes in B- and T-lymphocyte and chemokine levels with rituximab treatment in multiple sclerosis","volume":"67","author":"Piccio L","year":"2010","journal-title":"Arch Neurol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1177\/1352458511428465","article-title":"Disappearance of cerebrospinal fluid oligoclonal bands after natalizumab treatment of multiple sclerosis patients","volume":"18","author":"von Glehn F","year":"2012","journal-title":"Mult Scler"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/ana.20703","article-title":"Diagnostic criteria for multiple sclerosis: 2005 revisions to the \u00e2\u20ac\u02dcMcDonald Criteria\u00e2\u20ac\u2122","volume":"58","author":"Polman CH","year":"2005","journal-title":"Ann Neurol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jneuroim.2010.05.032","article-title":"The risk of relapse after a clinically isolated syndrome is related to the pattern of oligoclonal bands","volume":"226","author":"Bosc\u00e1 I","year":"2010","journal-title":"J Neuroimmunol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1212\/01.wnl.0000198253.35119.83","article-title":"Clinically isolated syndrome, a new oligoclonal band test accurately predicts conversion to MS","volume":"66","author":"Masjuan J","year":"2006","journal-title":"Neurology"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1212\/01.wnl.0000280576.73609.c6","article-title":"Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis","volume":"70","author":"Tintor\u00e9 M","year":"2008","journal-title":"Neurology"},{"key":"ref20","first-page":"24","article-title":"Clinical usefulness of cerebrospinal fluid evaluation","volume":"17","author":"Fredrikson S","year":"2009","journal-title":"Internat MS J"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-510X(94)90298-4","article-title":"Flow rate of cerebrospinal fluid (CSF)--a concept common to normal blood-CSF barrier function and to dysfunction in neurological diseases","volume":"122","author":"Reiber H","year":"1994","journal-title":"J Neurol Sci"},{"key":"ref22","first-page":"313","article-title":"Laboratory aids in the diagnosis of multiple sclerosis (MS)","volume":"146","author":"Tourtelotte WW","year":"1984","journal-title":"Prog Clin Biol Res"},{"key":"ref23","first-page":"99","article-title":"Cerebrospinal fluid--physiology, analysis and interpretation of protein patterns for diagnosis of neurological diseases","volume":"4","author":"Reiber H","year":"1998","journal-title":"Mult Scler"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0009-8981(87)90250-6","article-title":"Protein transfer at the blood cerebrospinal fluid barrier and the quantitation of the humoral immune response within the central nervous system","volume":"163","author":"Reiber H","year":"1987","journal-title":"Clin Chim Acta"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1212\/WNL.53.5.1107","article-title":"The clinical course of neuromyelitis optica (Devic's syndrome)","volume":"53","author":"Wingerchuk DM","year":"1999","journal-title":"Neurology"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon VA","year":"2004","journal-title":"Lancet"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nrneurol.2010.72","article-title":"AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance","volume":"6","author":"Jarius S","year":"2010","journal-title":"Nat Rev Neurol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s00415-010-5780-4","article-title":"Prognostic implications of aquaporin-4 antibody status in neuromyelitis optica patients","volume":"258","author":"Akman-Demir G","year":"2011","journal-title":"J Neurol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1742-2094-7-52","article-title":"Cerebrospinal fluid antibodies to aquaporin-4 in neuromyelitis optica and related disorders: frequency, origin, and diagnostic relevance","volume":"7","author":"Jarius S","year":"2010","journal-title":"J Neuroinflammation"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jns.2011.03.038","article-title":"Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures","volume":"306","author":"Jarius S","year":"2011","journal-title":"J Neurol Sci"},{"key":"ref31","first-page":"238","article-title":"Acute disseminated encephalomyelitis","volume":"50","author":"Murthy JM","year":"2002","journal-title":"Neurology India"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/WCO.0b013e3280f31b45","article-title":"Acute disseminated encephalomyelitis: an acute hit against the brain","volume":"20","author":"Menge T","year":"2007","journal-title":"Curr Opin Neurol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1001\/archneur.62.11.1673","article-title":"Acute disseminated encephalomyelitis: an update","volume":"62","author":"Menge T","year":"2005","journal-title":"Arch Neurol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jneuroim.2010.09.019","article-title":"Acute disseminated encephalomyelitis (ADEM)","volume":"231","author":"Wender M","year":"2010","journal-title":"J Neuroimmunol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/ana.21916","article-title":"Antibodies to native myelin oligodendrocyte glycoprotein in children with inflammatory demyelinating central nervous system disease","volume":"66","author":"Brilot F","year":"2009","journal-title":"Ann Neurol"}],"container-title":["Arquivos de Neuro-Psiquiatria"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/anp\/v71n9b\/0004-282X-anp-71-09b-685.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,27]],"date-time":"2017-05-27T12:20:10Z","timestamp":1495887610000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-282X2013001000685&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":35,"journal-issue":{"issue":"9B","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0004-282X2013001000685"],"URL":"https:\/\/doi.org\/10.1590\/0004-282x20130151","relation":{},"ISSN":["0004-282X"],"issn-type":[{"value":"0004-282X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}